Sandbox/00008: Difference between revisions

Jump to navigation Jump to search
No edit summary
mNo edit summary
Line 1: Line 1:
<div style="width: 1px; height: 1px; background-color: #999999; position: fixed; top: 10px; left: 10px"></div>
<div style="width: 90%; -webkit-user-select: none;">
==FIRE: Focused Initial Rapid Evaluation==
==FIRE: Focused Initial Rapid Evaluation==


A Focused Initial Rapid Evaluation (FIRE) should be performed to identify patients in need of immediate intervention.
A Focused Initial Rapid Evaluation (FIRE) should be performed to identify patients in need of immediate intervention.<ref name="Robin-2006">{{Cite journal  | last1 = Robin | first1 = E. | last2 = Costecalde | first2 = M. | last3 = Lebuffe | first3 = G. | last4 = Vallet | first4 = B. | title = Clinical relevance of data from the pulmonary artery catheter. | journal = Crit Care | volume = 10 Suppl 3 | issue =  | pages = S3 | month =  | year = 2006 | doi = 10.1186/cc4830 | PMID = 17164015 }}</ref>


<span style="font-size:85%">Boxes in the salmon color signify that an urgent management is needed.</span>
<span style="font-size:85%">Boxes in the salmon color signify that an urgent management is needed.</span>
Line 22: Line 26:
SaO2, arterial oxygen saturation;
SaO2, arterial oxygen saturation;
SBP, systolic blood pressure;
SBP, systolic blood pressure;
SCVO2, central venous oxygen saturation;
ScvO2, central venous oxygen saturation;
SMA-7, sequential multiple analysis-7.
SMA-7, sequential multiple analysis-7.
</span>
</span>
Line 31: Line 35:
❑&nbsp;&nbsp;Evidence of hypoperfusion
❑&nbsp;&nbsp;Evidence of hypoperfusion
: ❑&nbsp;&nbsp;[[Altered mental status|<span style="color: #000000;">Altered mental status</span>]]
: ❑&nbsp;&nbsp;[[Altered mental status|<span style="color: #000000;">Altered mental status</span>]]
: ❑&nbsp;&nbsp;[[Cool extremities|<span style="color: #000000;">Cool extremities</span>]]
: ❑&nbsp;&nbsp;[[Cold extremities|<span style="color: #000000;">Cold extremities</span>]]
: ❑&nbsp;&nbsp;[[Cyanosis|<span style="color: #000000;">Cyanosis</span>]]
: ❑&nbsp;&nbsp;[[Cyanosis|<span style="color: #000000;">Cyanosis</span>]]
: ❑&nbsp;&nbsp;[[Oliguria|<span style="color: #000000;">Oliguria</span>]]
: ❑&nbsp;&nbsp;[[Oliguria|<span style="color: #000000;">Oliguria</span>]]
Line 45: Line 49:
|A05=<div style="text-align: center; background: #FA8072; color: #FFFFFF; padding: 15px; font-weight: bold;"><BIG>'''Proceed to <br> [[shock resident survival guide|<span style="color: #FFFFFF;">shock resident survival guide</span>]] <br> to identify and correct the cause'''</BIG></div>}}
|A05=<div style="text-align: center; background: #FA8072; color: #FFFFFF; padding: 15px; font-weight: bold;"><BIG>'''Proceed to <br> [[shock resident survival guide|<span style="color: #FFFFFF;">shock resident survival guide</span>]] <br> to identify and correct the cause'''</BIG></div>}}
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| |!| | | | | | | | | |}}
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| |!| | | | | | | | | |}}
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| A06 | | | | | | | | |A06=<div style="background: #FA8072; color: #F8F8FF; padding: 15px;"><BIG>'''Immediate management'''</BIG>
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| A06 | | | | | | | | |A06=<div style="background: #FA8072; color: #F8F8FF; padding: 15px;"><BIG>'''[[{{PAGENAME}}#Immediate management|<span style="color: #FFFFFF;">Immediate management ''(click for details)''</span>]]'''</BIG>


❑&nbsp;&nbsp;[[Intubation|<span style="color: #FFFFFF;">Intubation</span>]] with [[mechanical ventilation|<span style="color: #FFFFFF;">mechanical ventilation</span>]]
❑&nbsp;&nbsp;[[Intubation|<span style="color: #FFFFFF;">Intubation</span>]] with [[mechanical ventilation|<span style="color: #FFFFFF;">mechanical ventilation</span>]]


❑&nbsp;&nbsp;± IV bolus [[Normal saline|<span style="color: #FFFFFF;">normal saline</span>]] 100–200 mL
❑&nbsp;&nbsp;± [[Norepinephrine|<span style="color: #FFFFFF;">Norepinephrine</span>]] IV infusion 0.1–2.0 μg/kg/min</div>}}
 
❑&nbsp;&nbsp;± [[Norepinephine|<span style="color: #FFFFFF;">Norepinephrine</span>]] 0.1–2.0 μg/kg/min
 
❑&nbsp;&nbsp;± Control pain and/or anxiety
: ❑&nbsp;&nbsp;[[Morphine sulphate|<span style="color: #FFFFFF;">Morphine sulphate</span>]]
 
: ❑&nbsp;&nbsp;[[Fentanyl|<span style="color: #FFFFFF;">Fentanyl</span>]]
 
❑&nbsp;&nbsp;[[Cardiology|<span style="color: #FFFFFF;">Cardiology consultation</span>]]</div>}}
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| |!| | | | | | | | | |}}
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| |!| | | | | | | | | |}}
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| A07 | | | | | | | | |A07=<div style="background: #FA8072; color: #F8F8FF; padding: 15px;"><BIG>'''Workup'''</BIG>
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| A07 | | | | | | | | |A07=<div style="background: #FA8072; color: #F8F8FF; padding: 15px;"><BIG>'''Immediate Workup'''</BIG>


❑&nbsp;&nbsp;[[ECG|<span style="color: #FFFFFF;">ECG monitor</span>]]
❑&nbsp;&nbsp;[[ECG|<span style="color: #FFFFFF;">ECG monitor</span>]]
Line 85: Line 80:


❑&nbsp;&nbsp;[[ICU|<span style="color: #FFFFFF;">ICU admission</span>]]
❑&nbsp;&nbsp;[[ICU|<span style="color: #FFFFFF;">ICU admission</span>]]
❑&nbsp;&nbsp;[[Cardiology|<span style="color: #FFFFFF;">Cardiology consultation</span>]]
❑&nbsp;&nbsp;Hold [[antihypertensive|<span style="color: #FFFFFF;">antihypertensive medications</span>]]
</div>}}
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| |!| | | | | | | | | |}}
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| A08 | | | | | | | | |A08=<div style="background: #FA8072; color: #F8F8FF; padding: 15px;"><BIG>'''Hemodynamic optimization: preload'''</BIG>
❑&nbsp;&nbsp;'''Goal: [[PCWP|<span style="color: #FFFFFF;">PCWP</span>]] 14–18 mm Hg'''
: ❑&nbsp;&nbsp;↑ [[PCWP|<span style="color: #FFFFFF;">PCWP</span>]] by [[Normal saline|<span style="color: #FFFFFF;">normal saline</span>]] IV bolus 100–200 mL
: ❑&nbsp;&nbsp;↓ [[PCWP|<span style="color: #FFFFFF;">PCWP</span>]] by [[Furosemide|<span style="color: #FFFFFF;">furosemide</span>]] slow IV injection (over 1–2 min)
: ❑&nbsp;&nbsp;± Correct [[{{PAGENAME}}#Immediate management|<span style="color: #FFFFFF;"> pulmonary congestion '''''(click for details)'''''</span>]]
: ❑&nbsp;&nbsp;± [[Morphine|<span style="color: #FFFFFF;">Morphine</span>]] 2–4 mg slow IV injection (over 1–5 min)
</div>}}
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| |!| | | | | | | | | |}}
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| A09 | | | | | | | | |A09=<div style="background: #FA8072; color: #F8F8FF; padding: 15px;"><BIG>'''Hemodynamic optimization: afterload'''</BIG>
❑&nbsp;&nbsp;'''Goal: [[MAP|<span style="color: #FFFFFF;">MAP</span>]] &gt;60 mm Hg, [[SVR|<span style="color: #FFFFFF;">SVR</span>]] 800–1200 dyn·s·cm<sup>−5</sup>'''
: ❑&nbsp;&nbsp;If ↑ MAP & ↑ SVR: wean [[vasopressor|<span style="color: #FFFFFF;">vasopressors</span>]] ± [[vasodilator|<span style="color: #FFFFFF;">vasodilators</span>]]
: ❑&nbsp;&nbsp;If ↓ MAP & ↑ SVR: [[vasopressor|<span style="color: #FFFFFF;">vasopressors</span>]] + [[inotrope|<span style="color: #FFFFFF;">inotropes</span>]]
: ❑&nbsp;&nbsp;If ↓ MAP & ↓ SVR: [[vasopressor|<span style="color: #FFFFFF;">vasopressors</span>]] ± [[vasopressin|<span style="color: #FFFFFF;">vasopressin</span>]]
</div>}}
</div>}}
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| |!| | | | | | | | | |}}
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| |!| | | | | | | | | |}}
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| A08 | | | | | | | | |A08=<div style="background: #FA8072; color: #F8F8FF; padding: 15px;"><BIG>'''Immediate goals'''</BIG>
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| A10 | | | | | | | | |A10=<div style="background: #FA8072; color: #F8F8FF; padding: 15px;"><BIG>'''Hemodynamic optimization: cardiac index'''</BIG>


❑&nbsp;&nbsp;[[SaO2|<span style="color: #FFFFFF;">SaO2 &gt;90%–92%</span>]]
❑&nbsp;&nbsp;'''Goal: [[CI|<span style="color: #FFFFFF;">CI</span>]] &gt;2.2 L/min/m<sup>2</sup>'''


❑&nbsp;&nbsp;[[CVP|<span style="color: #FFFFFF;">CVP 8–12 mm Hg</span>]]
: ❑&nbsp;&nbsp;± [[Dobutamine|<span style="color: #FFFFFF;">Dobutamine</span>]]


❑&nbsp;&nbsp;[[MAP|<span style="color: #FFFFFF;">MAP &gt;60 mm Hg</span>]]
: ❑&nbsp;&nbsp;± [[Milrinone|<span style="color: #FFFFFF;">Milrinone</span>]]
 
: ❑&nbsp;&nbsp;± [[IABP|<span style="color: #FFFFFF;">IABP</span>]], [[VAD|<span style="color: #FFFFFF;">VAD</span>]], or [[ECMO|<span style="color: #FFFFFF;">ECMO</span>]] if refractory</div>}}
 
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| |!| | | | | | | | | |}}
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| A11 | | | | | | | | |A11=<div style="background: #FA8072; color: #F8F8FF; padding: 15px;"><BIG>'''Immediate goals'''</BIG>


❑&nbsp;&nbsp;[[PCWP|<span style="color: #FFFFFF;">PCWP 14–18 mm Hg</span>]]
❑&nbsp;&nbsp;[[SaO2|<span style="color: #FFFFFF;">SaO2</span>]] &gt;90%–92%


❑&nbsp;&nbsp;[[cardiac index|<span style="color: #FFFFFF;">CI &gt;2.2 L/min/m2</span>]]
❑&nbsp;&nbsp;[[CVP|<span style="color: #FFFFFF;">CVP</span>]] 8–12 mm Hg


❑&nbsp;&nbsp;[[mixed venous oxygen saturation|<span style="color: #FFFFFF;">MVO2 &gt;60%</span>]]
❑&nbsp;&nbsp;[[mixed venous oxygen saturation|<span style="color: #FFFFFF;">MVO2</span>]] &gt;60%


❑&nbsp;&nbsp;[[SCVO2|<span style="color: #FFFFFF;">SCVO2 &gt;70%</span>]]
❑&nbsp;&nbsp;[[SCVO2|<span style="color: #FFFFFF;">ScvO2</span>]] &gt;70%


❑&nbsp;&nbsp;[[Hemoglobin|<span style="color: #FFFFFF;">Hemoglobin &gt;7–9 g/dL</span>]]
❑&nbsp;&nbsp;[[Hemoglobin|<span style="color: #FFFFFF;">Hemoglobin</span>]] &gt;7–9 g/dL


❑&nbsp;&nbsp;[[Lactate|<span style="color: #FFFFFF;">Lactate &lt;2.2 mM/L</span>]]
❑&nbsp;&nbsp;[[Lactate|<span style="color: #FFFFFF;">Lactate</span>]] &lt;2.2 mM/L


❑&nbsp;&nbsp;[[urine output|<span style="color: #FFFFFF;">Urine output >0.5 mL/kg/h</span>]]
❑&nbsp;&nbsp;[[urine output|<span style="color: #FFFFFF;">Urine output</span>]] >0.5 mL/kg/h


❑&nbsp;&nbsp;± Correct [[arrhythmia|<span style="color: #FFFFFF;">arrhythmia</span>]]
❑&nbsp;&nbsp;± Correct [[arrhythmia|<span style="color: #FFFFFF;">arrhythmia</span>]]
Line 113: Line 141:
❑&nbsp;&nbsp;± Correct [[electrolyte disturbance|<span style="color: #FFFFFF;">electrolyte disturbance</span>]]</div>}}
❑&nbsp;&nbsp;± Correct [[electrolyte disturbance|<span style="color: #FFFFFF;">electrolyte disturbance</span>]]</div>}}
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| |!| | | | | | | | | |}}
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| |!| | | | | | | | | |}}
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| A09 | | | | | | | | |A09=<div style="text-align: center; background: #FA8072; color: #FFFFFF; font-weight: bold; padding: 15px;"><BIG>Proceed to <br> [[{{PAGENAME}}#Complete Diagnostic Approach|<span style="color: #FFFFFF;">complete diagnostic approach</span>]] <br> below</BIG></div>}}
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| A12 |-| A13 | | | | | |A12=<div style="background: #FA8072; color: #F8F8FF; padding: 15px;"><BIG>'''[[{{PAGENAME}}#Immediate management|<span style="color: #FFFFFF;">ACS likely? ''(click for details)''</span>]]'''</BIG>
 
❑&nbsp;&nbsp;[[cardiac biomarkers|<span style="color: #FFFFFF;">Positive cardiac biomarkers (cTnT, cTnI, or CK-MB)</span>]]
 
❑&nbsp;&nbsp;Symptoms of myocaridal ischemia
 
❑&nbsp;&nbsp;New significant ECG findings of myocardial ischemia
 
</div>
|A13=<div style="text-align: center; background: #FA8072; color: #F8F8FF; padding: 16px;"><BIG><BIG>'''YES, then manage as <br> UA/STEMI <br> and proceed to <br> [[{{PAGENAME}}#Acute Ischemia Pathway|<span style="color: #FFFFFF;">acute ischemia pathway</span>]]'''</BIG></BIG>
 
</div>}}
 
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| |!| | | | | | | | | |}}
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| A14 | | | | | | | | |A14=<div style="text-align: center; background: #FA8072; color: #FFFFFF; font-weight: bold; padding: 15px;"><BIG>No, then proceed to <br> [[{{PAGENAME}}#Complete Diagnostic Approach|<span style="color: #FFFFFF;">complete diagnostic approach</span>]]</BIG></div>}}
{{Family tree/end}}
{{Family tree/end}}
==Acute Ischemia Pathway==
<!--return to top-->
==References==
{{reflist|2}}
[[Category:Disease]]
[[Category:Pulmonology]]
[[Category:Emergency medicine]]
[[Category:Medicine]]
[[Category:Resident survival guide]]

Revision as of 05:40, 21 April 2014

FIRE: Focused Initial Rapid Evaluation

A Focused Initial Rapid Evaluation (FIRE) should be performed to identify patients in need of immediate intervention.[1]

Boxes in the salmon color signify that an urgent management is needed.

Abbreviations: CBC, complete blood count; CI, cardiac index; CK-MB, creatine kinase MB isoform; CVP, central venous pressure; DC, differential count; ICU, intensive care unit; INR, international normalized ratio; LFT, liver function test; MAP, mean arterial pressure; MVO2, mixed venous oxygen saturation; PCWP, pulmonary capillary wedge pressure; PT, prothrombin time; PTT, partial prothrombin time; SaO2, arterial oxygen saturation; SBP, systolic blood pressure; ScvO2, central venous oxygen saturation; SMA-7, sequential multiple analysis-7.

 
 
 
 
Does the patient have cardinal findings that increase the pretest probability of cardiogenic shock?

❑  Evidence of hypoperfusion

❑  Altered mental status
❑  Cold extremities
❑  Cyanosis
❑  Oliguria
❑  Sustained hypotension
❑  SBP <90 mm Hg for ≥30 min or
❑  MAP ↓ >30 mm Hg below baseline for ≥30 min
❑  Presence of myocardial dysfunction after exclusion or correction of non-myocardial factors contributing to tissue hypoperfusion
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
YES
 
 
 
 
 
NO
 
 
 
 
 
 
 
 
 
 
 
 
 
Cardiogenic
shock
suspected
 
 
 
 
 
Proceed to
shock resident survival guide
to identify and correct the cause
 
 
 
 
 
 
 
 
 
 
 
 
Immediate management (click for details)

❑  Intubation with mechanical ventilation

❑  ± Norepinephrine IV infusion 0.1–2.0 μg/kg/min
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hemodynamic optimization: preload

❑  Goal: PCWP 14–18 mm Hg

❑  ↑ PCWP by normal saline IV bolus 100–200 mL
❑  ↓ PCWP by furosemide slow IV injection (over 1–2 min)
❑  ± Correct pulmonary congestion (click for details)
❑  ± Morphine 2–4 mg slow IV injection (over 1–5 min)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hemodynamic optimization: afterload

❑  Goal: MAP >60 mm Hg, SVR 800–1200 dyn·s·cm−5

❑  If ↑ MAP & ↑ SVR: wean vasopressors ± vasodilators
❑  If ↓ MAP & ↑ SVR: vasopressors + inotropes
❑  If ↓ MAP & ↓ SVR: vasopressors ± vasopressin
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hemodynamic optimization: cardiac index

❑  Goal: CI >2.2 L/min/m2

❑  ± Dobutamine
❑  ± Milrinone
❑  ± IABP, VAD, or ECMO if refractory
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Immediate goals

❑  SaO2 >90%–92%

❑  CVP 8–12 mm Hg

❑  MVO2 >60%

❑  ScvO2 >70%

❑  Hemoglobin >7–9 g/dL

❑  Lactate <2.2 mM/L

❑  Urine output >0.5 mL/kg/h

❑  ± Correct arrhythmia

❑  ± Correct electrolyte disturbance
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ACS likely? (click for details)

❑  Positive cardiac biomarkers (cTnT, cTnI, or CK-MB)

❑  Symptoms of myocaridal ischemia

❑  New significant ECG findings of myocardial ischemia

 
YES, then manage as
UA/STEMI
and proceed to
acute ischemia pathway
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No, then proceed to
complete diagnostic approach
 
 
 
 
 
 
 
 

Acute Ischemia Pathway

References

  1. Robin, E.; Costecalde, M.; Lebuffe, G.; Vallet, B. (2006). "Clinical relevance of data from the pulmonary artery catheter". Crit Care. 10 Suppl 3: S3. doi:10.1186/cc4830. PMID 17164015.